| | | | | |

Mesothelioma Risk Does Not Decline Over Time

asbestos banAnother published study is highlighting one of the most deadly aspects of malignant peritoneal mesothelioma – the fact that risk for the disease remains high even decades after asbestos exposure has ended.

This latest study is focused on peritoneal mesothelioma, a form of mesothelioma that begins on the membrane that surrounds the abdominal organs.

Although asbestos is now widely known to be the primary cause of mesothelioma, the Italian team that conducted the new research observes that few studies have been able to quantify the risk of peritoneal mesothelioma in the decades after exposure has stopped.

Peritoneal Mesothelioma Risk in Textile Workers

The study, conducted by scientists at several Italian universities, used as its subject a group of former textile workers. The group included 1,083 women and 894 men who were known to have been heavily exposed to asbestos, although the exposure was sometimes short-lived.

Among the 1,977 former textile workers, 1,019 had died. The researchers found that these workers were 29% more likely to die of peritoneal mesothelioma than the general public. These workers also had a 33% higher-than-average risk of dying of pleural mesothelioma.

The risk of these asbestos-exposed textile workers to die of lung cancer or ovarian cancer was also elevated.

No Decline in Mesothelioma Risk Over Time

One of the most important – and disturbing – findings of the study is that, although the risk of lung cancer began to drop off 25 years after exposure, the risk of contracting either pleural or peritoneal mesothelioma did not decline over time.

“The findings of this unique cohort provide novel data for peritoneal cancer, indicating that – as for pleural cancer – the excess risk does not decline up to several decades after cessation of exposure,” writes Professor Enrico Pira, MD, PhD, with the Department of Public Health Science and Pediatrics at Turin University.

The Biopersistence of Asbestos

One of the reasons that mesothelioma risk remains high among workers like the Italian textile employees even decades after asbestos exposure has ended is a quality called “biopersistence”.

Asbestos fibers are said to be biopersistent because their size and shape make it extremely difficult for the body to rid itself of them. The irritation and inflammation that happens at the cellular level because of continuous exposure to sharp, iron-rich asbestos fibers, is believed to trigger mesothelioma in some people. Studies have shown that certain genetic factors can compound the risk.

As with many cancers, mesothelioma survival is highest among people who are diagnosed earliest. People who know they have been exposed to asbestos, even if it was decades in the past, should see their doctor regularly and should be aware of mesothelioma symptoms, including fatigue, chest pain, breathing difficulty and cough.

Source:

Pira, E, et al, “Updated mortality study of a cohort of asbestos textile workers”, July 25, 2016, Cancer Medicine, Epub ahead of print

Similar Posts

  • | |

    Mesothelioma survivor Paul Kraus, alive and well 19 years after writing “Surviving Mesothelioma and Other Cancers

    Paul Kraus is considered the longest documented mesothelioma survivor in the world. He was diagnosed in 1997 with mesothelioma so widespread that he was given little hope of survival. Not willing to give up, he worked with a team of doctors to create his own tailored treatment protocol. This protocol included dramatic life style change, experimental therapies, dietary changes, mind-body medicine, and other modalities. Paul was fortunate. The protocol he and his doctors created helped him keep the mesothelioma in check. His book “Surviving Mesothelioma and Other Cancers: A Patient’s Guide” details his cancer voyage, the decisions he made, and his philosophies about health and healing. This book is now the best-selling mesothelioma book in the world and has inspired…

  • | |

    Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma

    A team of medical researchers in Italy have achieved what they are calling “excellent” tumor control and survival results in malignant pleural mesothelioma patients using a combination of surgery, chemotherapy, and radiotherapy. Caused by exposure to asbestos, mesothelioma typically spreads quickly across the lung-encasing membrane called the pleura. There is no known cure but treatments are improving. In the current prospective study, 20 malignant pleural mesothelioma patients underwent radical pleurectomy/decortication followed by high doses of radiation. After surgeons removed as much of the visible mesothelioma tumor and surrounding tissue as possible, patients received 50Gy of radiation to the effected side of their chest, delivered in 25 fractions. Regions of particular concern for mesothelioma regrowth got an extra radiation “boost” to…

  • |

    Mesothelioma Still Rising Despite Ban in Ireland

    A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

  • | |

    Does Radiotherapy Reduce Mesothelioma Pain?

    A new study says there is not enough evidence to support the use of radiotherapy for the treatment of pain associated with malignant pleural mesothelioma. Researchers at the University of Edinburgh in Scotland reviewed a range of past studies on mesothelioma pain and radiotherapy by searching databases that date back as far as 1974. To be eligible to be included in their review, the study had to focus on malignant pleural mesothelioma and radiotherapy given “with the intent of improving pain”. The study also had to report doses and fractionation of the radiotherapy and how the pain responded. In all, the researchers found eight studies on mesothelioma pain and radiotherapy that met the criteria. Two of the studies were prospective…

  • |

    Website Aims to Protect Homeowners from Mesothelioma

    Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

  • |

    Ape Virus Shrinks Mesothelioma Tumors in Lab

    A virus that causes leukemia in gibbon apes may have the power to help fight malignant mesothelioma in people. Gibbon ape leukemia virus (GALV) has been tested for years as a viral vector, a carrier of therapeutic genetic information, in the treatment of various human illnesses, including cancer. A new study in Japan compared GALV with a leukemia virus derived from mice to see which carrier communicated most efficiently with mesothelioma cells. While both types of viruses replicated in most of the mesothelioma cell lines tested, the mouse-derived virus was not effective in a mesothelioma cell line called ACC-MESO-1. In this cell line, only the GALV spread efficiently both in culture and in mice that had been given human mesothelioma…